Cardiological effects of sertindole, haloperidol, and placebo in schizophrenic patients

被引：0
|
作者：
Lancon, C [1 ]
Valli, M [1 ]
Toumi, M [1 ]
机构：
[1] Univ Aix Marseille 2, Dept Psychiat, F-13284 Marseille 07, France
来源：
SCHIZOPHRENIA RESEARCH | 1999年 / 36卷 / 1-3期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：356 / 356
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of three doses of sertindole and haloperidol in schizophrenic patients
    Bark, N
    Mack, R
    Zborowski, J
    Morris, D
    Sebree, T
    Shook, S
    Wallin, B
    [J]. BIOLOGICAL PSYCHIATRY, 1996, 39 (07) : 332 - 332
  • [2] The efficacy and safety of three doses of sertindole versus three doses of haloperidol in schizophrenic patients
    Ereshefsky, L
    Mack, RJ
    Morris, DD
    Sebree, TB
    Wallin, B
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (03) : 441 - 441
  • [3] Brain imaging to determine the effects of sertindole in schizophrenic patients
    Potkin, S
    Zborowski, J
    Wu, J
    Mack, R
    Bera, R
    Sebree, T
    Aurang, C
    Bunney, W
    [J]. BIOLOGICAL PSYCHIATRY, 1996, 39 (07) : 52 - 52
  • [4] Brain imaging to determine the effects of sertindole in schizophrenic patients
    Potkin, SG
    Zborowski, J
    Wu, J
    Mack, R
    Aurang, C
    Sebree, T
    Carreon, D
    Bera, R
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (03) : 498 - 498
  • [5] Brain imaging to determine the effects of sertindole in a double-blind, placebo-controlled trial in schizophrenic patients
    Potkin, S
    Zborowski, J
    Wu, J
    Giles, K
    Bera, R
    Henry, M
    Sebree, T
    Aurang, C
    Wallin, B
    Bunney, W
    [J]. SCHIZOPHRENIA RESEARCH, 1996, 18 (2-3) : XIIE4 - XIIE4
  • [6] A one-year, controlled cost-effectiveness study comparing sertindole and haloperidol in stable schizophrenic patients
    Chang, R
    Swann, AC
    Becker, L
    Wozniak, PG
    McCarthy, BG
    [J]. BIOLOGICAL PSYCHIATRY, 1998, 43 : 117S - 117S
  • [7] PK-PD of sertindole in schizophrenic patients
    Samara, E
    Granneman, R
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : OIIB2 - OIIB2
  • [8] EFFICACY AND SAFETY OF SERTINDOLE IN DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS OF SCHIZOPHRENIC-PATIENTS
    MARTIN, PT
    GREBB, JA
    SCHMITZ, PJ
    SEBREE, TB
    KASHKIN, KB
    [J]. SCHIZOPHRENIA RESEARCH, 1994, 11 (02) : 107 - 107
  • [9] PHARMACOKINETICS OF HALOPERIDOL AND HALOPERIDOL DECANOATE IN SCHIZOPHRENIC-PATIENTS
    NAYAK, RK
    NAIR, NPV
    DOOSE, DR
    MCCARTHY, LR
    DESIRAJU, RK
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (02) : 217 - 217
  • [10] Clinical observations of sertindole-treated schizophrenic patients
    Bickmann, E
    Grosse, K
    Laux, G
    [J]. PSYCHOPHARMAKOTHERAPIE, 2001, 8 (01): : 28 - 34
12345